|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|
| Operating expenses: | ||
| Research and development | ||
| General and administrative | ||
| Total operating expenses | ||
| Loss from operations | ||
| Other (expense) income: | ||
| Change in fair value of contingent earn-out liability | ||
| Change in fair value of warrant liabilities | ||
| Interest income, net | ||
| Other expense, net | ||
| Total other income, net | ||
| Net loss | ||
| Other comprehensive income (loss), net of tax: | ||
| Foreign currency translation adjustments | ||
| Unrealized holding losses on short-term investments | ||
| Comprehensive loss, net of tax | ||
| Net loss attributable to common stockholders - basic | ||
| Net loss attributable to common stockholders - diluted | ||
| Net loss per share - basic (in dollars per share) | ||
| Net loss per share - diluted (in dollars per share) | ||
| Weighted average common shares outstanding - basic (in shares) | ||
| Weighted average common shares outstanding - diluted (in shares) |
Loading...
